Company / Operating Cash Flow
ARS Pharmaceuticals, Inc. Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$170.9M
FY2025
5-year range
-$170.9M / $13.5M
FY2021-FY2025
Trend
-1361.2%
vs FY2024
Sector context
#157 of 216
Health Care
What the data says
Operating Cash Flow changed -1361% YoY in FY2025, a notable deviation from the 5-year average annual change of -286%.
Based on SEC 10-K filings.
-$171M in FY2025.
Declined from -$59M to -$171M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#157 of 216 in Health CareTop 73% of 216This company -$170.9M Sector average $658.7M
▼
-125.9% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 1361.2% year-over-year.
- Ranks #157 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$170.9M | -1361.2% |
| FY2024 | $13.5M | +122.9% |
| FY2023 | -$59.3M | -237.5% |
| FY2022 | -$17.6M | +0.0% |
| FY2021 | -$17.6M | +43.7% |
| FY2020 | -$31.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026